These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8251371)

  • 1. Mechanism of drug-induced inhibition of keratinocyte proliferation: antagonism of calmodulin or inhibition of protein kinase C?
    Hegemann L; Mahrle G
    Br J Dermatol; 1993 Nov; 129(5):644-5. PubMed ID: 8251371
    [No Abstract]   [Full Text] [Related]  

  • 2. Potent antagonism of calmodulin activity in vitro, but lack of antiproliferative effects on keratinocytes by the novel leukotriene biosynthesis inhibitor MK-886.
    Hegemann L; Hatzelmann A; Grewig S; Schmidt BH
    Br J Dermatol; 1995 Jul; 133(1):41-7. PubMed ID: 7669639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-proliferative effects of protein kinase C inhibitors in human keratinocytes.
    Hegemann L; Bonnekoh B; van Rooijen LA; Mahrle G
    J Dermatol Sci; 1992 Jul; 4(1):18-25. PubMed ID: 1390454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tiflucarbine as a dual protein kinase C/calmodulin antagonist on proliferation of human keratinocytes and release of reactive oxygen species from human leukocytes.
    Hegemann L; Fruchtmann R; Bonnekoh B; Schmidt BH; Traber J; Mahrle G; Müller-Peddinghaus R; van Rooijen LA
    Arch Dermatol Res; 1991; 283(7):456-60. PubMed ID: 1801655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ca(2+)/calmodulin-dependent protein kinase (CaM-kinase) inhibitor KN-62 suppresses the activity of mitogen-activated protein kinase (MAPK), c-myc activation and human keratinocyte proliferation.
    Praskova M; Kalenderova S; Miteva L; Poumay Y; Mitev V
    Arch Dermatol Res; 2002 Jul; 294(4):198-202. PubMed ID: 12111351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of epidermal cell morphology and keratin expression induced by inhibitors of protein kinase C.
    Hegemann L; Wevers A; Bonnekoh B; Mahrle G
    J Dermatol Sci; 1992 Mar; 3(2):103-10. PubMed ID: 1376142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between inhibition of protein kinase C and antagonism of calmodulin by tamoxifen analogues.
    Rowlands MG; Budworth J; Jarman M; Hardcastle IR; McCague R; Gescher A
    Biochem Pharmacol; 1995 Aug; 50(5):723-6. PubMed ID: 7669076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiproliferative effects on keratinocytes of a range of clinically used drugs with calmodulin antagonist activity.
    Mac Neil S; Dawson RA; Crocker G; Tucker WF; Bittiner B; Singleton JG; Hunter T; Tierney DF
    Br J Dermatol; 1993 Feb; 128(2):143-50. PubMed ID: 8457447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential modulation of human fibroblast and keratinocyte growth by the protein kinase C inhibitor GF 109203X.
    Le Panse R; Coulomb B; Mitev V; Bouchard B; Lebreton C; Dubertret L
    Mol Pharmacol; 1994 Sep; 46(3):445-51. PubMed ID: 7935324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis.
    Wilkinson JD; Williamson EM
    J Dermatol Sci; 2007 Feb; 45(2):87-92. PubMed ID: 17157480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calmodulin-antagonism inhibits human keratinocyte proliferation.
    Eichelberg D; Fuchs A
    Arch Dermatol Res; 1988; 280(5):323-4. PubMed ID: 2460037
    [No Abstract]   [Full Text] [Related]  

  • 12. Calmodulin inhibition by anthralin? Investigations in vitro and in vivo.
    Wollina U; Klinger R; Wetzker R; Knopf B
    Dermatologica; 1989; 179(2):61-3. PubMed ID: 2529149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium/calmodulin regulation of the proliferation of human epidermal keratinocytes, dermal fibroblasts and mouse B16 melanoma cells in culture.
    Al-Ani AM; Messenger AG; Lawry J; Bleehen SS; MacNeil S
    Br J Dermatol; 1988 Sep; 119(3):295-306. PubMed ID: 2460125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ciclosporin A on epidermal keratinocytes in vitro: lack of a direct effect on calmodulin.
    Fairley JA; Fung PD; Ewing NM
    Skin Pharmacol; 1990; 3(3):149-56. PubMed ID: 2078349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Putative conventional protein kinase C inhibitor Gödecke 6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] stimulates transglutaminase activity in primary mouse epidermal keratinocytes.
    Shapiro BA; Ray S; Jung E; Allred WT; Bollag WB
    J Pharmacol Exp Ther; 2002 Jul; 302(1):352-8. PubMed ID: 12065737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calmodulin antagonism and growth-inhibiting activity of triphenylethylene antiestrogens in MCF-7 human breast cancer cells.
    Gulino A; Barrera G; Vacca A; Farina A; Ferretti C; Screpanti I; Dianzani MU; Frati L
    Cancer Res; 1986 Dec; 46(12 Pt 1):6274-8. PubMed ID: 3022916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosiglitazone inhibits proliferation, motility, and matrix metalloproteinase production in keratinocytes.
    Bhagavathula N; Nerusu KC; Lal A; Ellis CN; Chittiboyina A; Avery MA; Ho CI; Benson SC; Pershadsingh HA; Kurtz TW; Varani J
    J Invest Dermatol; 2004 Jan; 122(1):130-9. PubMed ID: 14962101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nerve growth factor modulates keratinocyte proliferation in murine skin organ culture.
    Paus R; Lüftl M; Czarnetzki BM
    Br J Dermatol; 1994 Feb; 130(2):174-80. PubMed ID: 8123570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphodiesterase 7A inhibitor ASB16165 impairs proliferation of keratinocytes in vitro and in vivo.
    Goto M; Kadoshima-Yamaoka K; Murakawa M; Yoshioka R; Tanaka Y; Inoue H; Murafuji H; Kanki S; Hayashi Y; Nagahira K; Ogata A; Nakatsuka T; Fukuda Y
    Eur J Pharmacol; 2010 May; 633(1-3):93-7. PubMed ID: 20132810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of tazarotene action in psoriasis.
    Duvic M; Nagpal S; Asano AT; Chandraratna RA
    J Am Acad Dermatol; 1997 Aug; 37(2 Pt 3):S18-24. PubMed ID: 9270552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.